Details for New Drug Application (NDA): 215652
✉ Email this page to a colleague
The generic ingredient in ALBENDAZOLE is albendazole. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the albendazole profile page.
Summary for 215652
Tradename: | ALBENDAZOLE |
Applicant: | Alembic |
Ingredient: | albendazole |
Patents: | 0 |
Pharmacology for NDA: 215652
Mechanism of Action | Cytochrome P450 1A Inducers |
Medical Subject Heading (MeSH) Categories for 215652
Suppliers and Packaging for NDA: 215652
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALBENDAZOLE | albendazole | TABLET;ORAL | 215652 | ANDA | Alembic Pharmaceuticals Limited | 46708-681 | 46708-681-02 | 2 TABLET, FILM COATED in 1 BOTTLE (46708-681-02) |
ALBENDAZOLE | albendazole | TABLET;ORAL | 215652 | ANDA | Alembic Pharmaceuticals Limited | 46708-681 | 46708-681-28 | 28 TABLET, FILM COATED in 1 BOTTLE (46708-681-28) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Sep 4, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription